CJC-1295 without DAC 5MG + IPA 5MG

CJC-1295 (Without DAC) 5MG + Ipamorelin 5MG Vial — Premium Research-Grade Growth Hormone Peptide Stack

A precisely formulated dual-peptide vial containing CJC-1295 (Without DAC) 5MG and Ipamorelin 5MG, developed for researchers investigating compounds associated with growth hormone signalling, endocrine pathways, and metabolic research. Each vial is produced to exacting research-grade standards, ensuring exceptional consistency, purity, and reliability across every batch.

The combination of CJC-1295 (Without DAC) and Ipamorelin has attracted significant scientific interest due to the complementary nature of their mechanisms of interest. As one of the most recognised peptide stacks within growth hormone-related research, this formulation has become increasingly sought after by researchers exploring pulsatile growth hormone release models and endocrine function.

For larger research requirements, CJC-1295 (Without DAC) 5MG + Ipamorelin 5MG is also available in convenient multi-vial bundles of 10 directly from the product selection menu.

Blend Specifications

Each vial contains:

• CJC-1295 (Without DAC) — 5MG

• Ipamorelin — 5MG

Total peptide content: 10MG per vial

• High-purity formulations — manufactured under rigorous quality controls

• Securely sealed and packaged to preserve integrity during storage and transit

• Suitable for in vitro and laboratory research applications

Research Context

CJC-1295 (Without DAC) is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has generated considerable scientific interest due to its interactions with pathways involved in endogenous growth hormone secretion.

Ipamorelin is a selective growth hormone secretagogue that continues to be investigated for its activity involving ghrelin receptor signalling and growth hormone-related research models.

Due to their distinct yet complementary areas of investigation, researchers frequently explore these compounds in combination when studying broader aspects of endocrine signalling and growth hormone dynamics.

As a result, the pairing of CJC-1295 (Without DAC) and Ipamorelin has become one of the most established and widely recognised stacks within peptide-based endocrine research.

Why Researchers Are Interested in CJC-1295 + Ipamorelin

• Significant interest within growth hormone and endocrine research

• Ongoing investigations into endogenous growth hormone signalling pathways

• Research exploring GHRH analogue and growth hormone secretagogue interactions

• One of the most recognised peptide combinations within this area of scientific investigation

• Increasing attention surrounding their complementary research profiles

Related Research Compounds

Researchers exploring CJC-1295 (Without DAC) and Ipamorelin may also be interested in:

• Tesamorelin

• CJC-1295 (With DAC)

• MK-677

• MOTS-C

• NAD+

While these compounds differ in their mechanisms of interest, they share overlapping areas of scientific investigation involving growth hormone pathways, metabolic research, and peptide science.

For Research Purposes Only. This product is strictly intended for laboratory and in vitro research use only. It is not intended for human administration, clinical use, diagnosis, treatment, prevention of disease, or resale for investigational purposes.

Each product is professionally third-party tested, with Certificates of Analysis (COAs) available for quality assurance and research verification.

Precision. Purity. Consistency.